Jörg Engelmann

Photo

CAC Develops Promising Synthetic Gas To Fuel Method

Jörg Engelmann, Managing Director of CAC, explains: "We are looking for ideas, focussing on finding solutions for the future. If through our expertise we can identify new paths and get around obstacles, we will get there in the end. Visit us at ACHEMA 2015, hall 9.1, stand B26. "

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.